IL184560A0 - Cci-779 polymorph and use thereof - Google Patents
Cci-779 polymorph and use thereofInfo
- Publication number
- IL184560A0 IL184560A0 IL184560A IL18456007A IL184560A0 IL 184560 A0 IL184560 A0 IL 184560A0 IL 184560 A IL184560 A IL 184560A IL 18456007 A IL18456007 A IL 18456007A IL 184560 A0 IL184560 A0 IL 184560A0
- Authority
- IL
- Israel
- Prior art keywords
- cci
- polymorph
- Prior art date
Links
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 title 1
- 229960000235 temsirolimus Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65137405P | 2005-02-09 | 2005-02-09 | |
| PCT/US2006/003098 WO2006086172A1 (en) | 2005-02-09 | 2006-01-25 | Cci-779 polymorph and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL184560A0 true IL184560A0 (en) | 2007-10-31 |
Family
ID=36570939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL184560A IL184560A0 (en) | 2005-02-09 | 2007-07-12 | Cci-779 polymorph and use thereof |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7442707B2 (https=) |
| EP (1) | EP1856130A1 (https=) |
| JP (1) | JP2008530090A (https=) |
| KR (1) | KR20070107030A (https=) |
| CN (1) | CN101115759A (https=) |
| AR (1) | AR052479A1 (https=) |
| AU (1) | AU2006213061A1 (https=) |
| BR (1) | BRPI0607932A2 (https=) |
| CA (1) | CA2595766A1 (https=) |
| CR (1) | CR9257A (https=) |
| GT (1) | GT200600044A (https=) |
| IL (1) | IL184560A0 (https=) |
| MX (1) | MX2007009590A (https=) |
| NO (1) | NO20073725L (https=) |
| PE (1) | PE20060996A1 (https=) |
| RU (1) | RU2007129264A (https=) |
| TW (1) | TW200638932A (https=) |
| WO (1) | WO2006086172A1 (https=) |
| ZA (1) | ZA200706628B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551512B2 (en) | 2004-03-22 | 2013-10-08 | Advanced Cardiovascular Systems, Inc. | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS |
| BRPI0619592A2 (pt) * | 2005-12-07 | 2016-09-06 | Wyeth Corp | métodos para medir a qualidade da partícula de um composto de rapamicina, para determinar o tamanho de partícula médio de uma amostra e a cristalinidade de um composto de rapamicina, e para a purificação de rapamicina |
| AR058282A1 (es) * | 2005-12-07 | 2008-01-30 | Wyeth Corp | Forma cristalina purificada de cci-779, un proceso para la preparacion del mismo, un metodo para monitorear la cristalizacion del cci-779, un kit y una composicion farmaceutica que lo comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer. |
| US7622578B2 (en) * | 2005-12-07 | 2009-11-24 | Wyeth | Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate |
| TW200824713A (en) * | 2006-10-18 | 2008-06-16 | Wyeth Corp | Processes for the synthesis of individual isomers of mono-PEG CCI-779 |
| EP2380006A4 (en) * | 2009-01-21 | 2012-05-16 | Biocon Ltd | PROCESS FOR DETERMINING THE SIROLIMUS STABILITY AND METHOD FOR PRODUCING ITS STABLE FORM |
| US10682415B2 (en) | 2013-07-22 | 2020-06-16 | Wisconsin Alumni Research Foundation | Thermogel formulation for combination drug delivery |
| CN109020995A (zh) * | 2017-06-12 | 2018-12-18 | 鲁南制药集团股份有限公司 | 一种替西罗莫司的晶型物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
| TWI256395B (en) | 1999-09-29 | 2006-06-11 | Wyeth Corp | Regioselective synthesis of rapamycin derivatives |
| US6277983B1 (en) * | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
| BR0211986A (pt) * | 2001-08-22 | 2004-09-28 | Wyeth Corp | 29-enóis de rapamicina |
| MXPA04001523A (es) | 2001-08-22 | 2004-05-31 | Wyeth Corp | Dialdehidos de rapamicina. |
| WO2005010010A1 (en) | 2003-07-16 | 2005-02-03 | Wyeth | Cci-779 isomer c |
| KR20060057605A (ko) | 2003-08-07 | 2006-05-26 | 와이어쓰 | Ｃｃｉ-779의 위치선택적 합성 방법 |
| RU2345999C2 (ru) | 2003-09-03 | 2009-02-10 | Уайт | Аморфный 42-эфир рапамицина и 3-гидрокси-2(гидроксиметил)-2-метилпропионовой кислоты и содержащие его фармацевтические композиции |
| JP4224115B2 (ja) * | 2004-04-14 | 2009-02-12 | ワイス | ラパマイシン４２−エステル誘導体の位置特異的合成 |
-
2006
- 2006-01-25 CA CA002595766A patent/CA2595766A1/en not_active Abandoned
- 2006-01-25 RU RU2007129264/04A patent/RU2007129264A/ru not_active Application Discontinuation
- 2006-01-25 US US11/339,728 patent/US7442707B2/en not_active Expired - Fee Related
- 2006-01-25 WO PCT/US2006/003098 patent/WO2006086172A1/en not_active Ceased
- 2006-01-25 BR BRPI0607932A patent/BRPI0607932A2/pt not_active IP Right Cessation
- 2006-01-25 JP JP2007555124A patent/JP2008530090A/ja not_active Withdrawn
- 2006-01-25 CN CNA200680004408XA patent/CN101115759A/zh not_active Withdrawn
- 2006-01-25 MX MX2007009590A patent/MX2007009590A/es not_active Application Discontinuation
- 2006-01-25 AU AU2006213061A patent/AU2006213061A1/en not_active Abandoned
- 2006-01-25 EP EP06734012A patent/EP1856130A1/en not_active Withdrawn
- 2006-01-25 KR KR1020077018347A patent/KR20070107030A/ko not_active Withdrawn
- 2006-02-03 PE PE2006000136A patent/PE20060996A1/es not_active Application Discontinuation
- 2006-02-06 TW TW095103902A patent/TW200638932A/zh unknown
- 2006-02-07 GT GT200600044A patent/GT200600044A/es unknown
- 2006-02-08 AR ARP060100451A patent/AR052479A1/es unknown
-
2007
- 2007-07-12 IL IL184560A patent/IL184560A0/en unknown
- 2007-07-18 NO NO20073725A patent/NO20073725L/no not_active Application Discontinuation
- 2007-07-18 CR CR9257A patent/CR9257A/es not_active Application Discontinuation
- 2007-08-08 ZA ZA200706628A patent/ZA200706628B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2595766A1 (en) | 2006-08-17 |
| NO20073725L (no) | 2007-09-05 |
| GT200600044A (es) | 2006-11-09 |
| AU2006213061A1 (en) | 2006-08-17 |
| US7442707B2 (en) | 2008-10-28 |
| AR052479A1 (es) | 2007-03-21 |
| MX2007009590A (es) | 2007-09-12 |
| CR9257A (es) | 2007-11-23 |
| PE20060996A1 (es) | 2006-11-13 |
| WO2006086172A1 (en) | 2006-08-17 |
| ZA200706628B (en) | 2010-01-27 |
| JP2008530090A (ja) | 2008-08-07 |
| TW200638932A (en) | 2006-11-16 |
| CN101115759A (zh) | 2008-01-30 |
| EP1856130A1 (en) | 2007-11-21 |
| KR20070107030A (ko) | 2007-11-06 |
| RU2007129264A (ru) | 2009-03-20 |
| BRPI0607932A2 (pt) | 2016-11-08 |
| US20060178392A1 (en) | 2006-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL181170A0 (en) | Rapamycin polymorph ii and uses thereof | |
| EP1951680A4 (en) | NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE | |
| GB0512940D0 (en) | Compounds and their use | |
| IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
| IL181675A0 (en) | Diphenylethylene compounds and uses thereof | |
| IL189252A0 (en) | Dihydroxyanthraquinones and their use | |
| ZA200706628B (en) | CCI-779 polymorph and use thereof | |
| EP2077262A4 (en) | IMINOPYRIDINE DERIVATIVE AND USE THEREOF | |
| IL185223A0 (en) | Compounds and uses thereof | |
| GB0520743D0 (en) | Compounds and their use | |
| IL192820A0 (en) | Novel compounds and use thereof | |
| EP1810976A4 (en) | BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND THE USE THEREOF | |
| HK1110590A (en) | Cci-779 polymorph and use thereof | |
| ZA200804378B (en) | Iminopropene compound and use thereof | |
| GB0427723D0 (en) | Compounds and their use | |
| GB0521278D0 (en) | Compounds and their use | |
| GB0513176D0 (en) | Compounds and their use | |
| GB0401243D0 (en) | Compounds and their use | |
| GB0410831D0 (en) | Compounds and their use | |
| GB0411071D0 (en) | Compounds and their use | |
| GB0402905D0 (en) | Compounds and their use | |
| GB0410832D0 (en) | Compounds and their use | |
| GB0410833D0 (en) | Compounds and their use | |
| GB0416630D0 (en) | Compounds and their use | |
| GB0423234D0 (en) | Compounds and their use |